Gufic BioSciences Faces Mildly Bearish Trends Amid Strong Management Efficiency and Profit Decline
Gufic BioSciences has recently experienced an evaluation adjustment, reflecting a mildly bearish technical trend influenced by various metrics. Despite facing profit declines, the company maintains strong management efficiency with a high Return on Capital Employed and a low Debt to EBITDA ratio, highlighting its capacity to manage debt obligations.
Gufic BioSciences, a small-cap player in the Pharmaceuticals & Drugs industry, has recently undergone an adjustment in evaluation, reflecting shifts in its technical indicators. The company's technical trend has transitioned to a mildly bearish stance, influenced by various metrics. The MACD shows a bearish signal on a weekly basis, while the monthly perspective indicates a mildly bearish outlook. Additionally, the Bollinger Bands and KST metrics align with this mildly bearish trend, suggesting a cautious market sentiment.Despite these technical adjustments, Gufic BioSciences has demonstrated notable management efficiency, evidenced by a high Return on Capital Employed (ROCE) of 15.3. However, the company has faced challenges, including a decline in profits over the past year, which contrasts with its stock performance that yielded a return of 16.06%. The financial landscape reveals a low Debt to EBITDA ratio of 1.41 times, indicating a strong capacity to manage debt obligations.
As Gufic BioSciences navigates these dynamics, the recent evaluation adjustment underscores the importance of monitoring underlying trends and performance indicators in the pharmaceutical sector.
Discover the Latest Mojo Score and Financial Trend Performance - SignUp in less than 2 Minutes and get FREE Premium Access.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
